What recent evidence do we have that omicron is evading immunity and what are the implications?

Information
information_group_1
Type of settings
On-line
Category of capacity building activity
Seminar/Webinar
COVID-19 related
Yes
PHIRI Activity
No
Activity schedule
Fixed date(s)
information_group_dates
Activity local date
-
Capacity Building Activity URL
https://www.who.int/news-room/events/detail/2022/02/14/default-calendar/save-th…
information_group_2
GEO coverage
Multinational
Language
English
Available in other languages
No
Target audience
Junior specialists;
Experts;
Public Health Sector;
Public Health Professionals;
Public Health Authorities

In continuation to the scientific discussions on COVID-19 vaccines research, WHO R&D Blueprint organized a follow-up consultation to review emerging data related to the omicron variant. During this forthcoming consultation global experts reviewed the available evidence, critically appraised the data, and summarized the interpretation of evidence and next steps.

Topics
Health status » Morbidity/disability » Communicable diseases » Covid-19;
Health systems » Health system performance » Quality » Vaccination coverage;
Policy » Response Plan
organization_group
Leading organizer
World Health Organisation
Contact

WHO Headquarters in Geneva

Telephone: +41 22 791 21 11 | Website (link in here)

Updated on 28 April 2022